Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing

Transfusion

Volumn 54, Issue 12, 2014, Pages 3247-3251

  Katz, Louis M ^a,b   Tobian, Aaron A R ^c  

^a America's Blood Centers   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(METHYL METHACRYLATE);

AFRICA; BODILY SECRETIONS; BODY FLUID; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; GLOVE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LABORATORY PERSONNEL; LABORATORY TEST; MALARIA FALCIPARUM; MASK; REVIEW; RISK ASSESSMENT; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; DEVICES; FEMALE; HEMORRHAGIC FEVER, EBOLA; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PROCEDURES; PROTECTIVE EQUIPMENT; RISK FACTOR; TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; COMMUNICABLE DISEASE CONTROL; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; LABORATORY PERSONNEL; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINES AS TOPIC; PROTECTIVE DEVICES; RISK FACTORS;

EID: 84916607970     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12913     Document Type: Review

References (28)

1. Hampton T,. Largest-ever outbreak of Ebola virus disease thrusts experimental therapies, vaccines into spotlight. JAMA 2014; 312: 987-989.
2. World Health Organization. Barriers to rapid containment of the Ebola outbreak. Geneva: World Health Organization; 2014 [cited 2014 Sep 2]. Available from: http://www.who.int/csr/disease/ebola/overview-august-2014/en
3. Stephenson J,. CDC: Ebola risk to US patients is low, but clinicians should be on alert. JAMA 2014; 312: 686.
4. Centers for Disease Control and Prevention. Information for healthcare workers. 2014 [cited 2014 Sep 3]. Available from: http://www.cdc.gov/vhf/ebola/hcp/index.html
5. Public Health England. Guidance: Ebola virus disease: identifying and managing patients for assessment in acute trusts. 2014 [cited 2014 Sep 3]. Available from: https://www.gov.uk/government/publications/ebola-virus-disease-identifying-and-managing-patients-for-assessment-in-acute-trusts
6. Commonwealth Department of Health and Aged Care. Laboratory precautions for samples collected from patients with suspected viral haemorrhagic fevers. 2014 [cited 2014 Sep 3]. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-other-vhf.htm
7. The Commonwealth of Massachusetts. Laboratory risk assessment for a suspect patient with a high possibility of Ebola virus disease (EVD). Revised: August 25, 2014 [cited 2014 Sep 2]. Available from: http://www.mass.gov/eohhs/gov/departments/dph/programs/emergency-prep/threats/biological/ebola-virus.html
8. New York State Department of Health. Health Advisory: Interim NYS/NYC laboratory guidelines for handling specimens from cases or suspected cases of Ebola virus disease. 2014 [cited 2014 Sep 2]. Available from: http://www.nyc.gov/cgi-bin/exit.pl?url=https://apps.health.ny.gov/pub/ctrldocs/alrtview/postings/Notification-17105.pdf
9. Fauci FS,. Ebola-underscoring the global disparities in health care resources. N Engl J Med 2014; 371: 1084-1086.
10. World Health Organization. Ebola virus disease. Fact sheet No. 103. 2014 [cited 2014 Aug 31]. Available from: http://www.who.int/mediacentre/factsheets/fs103/en/
11. Feldmann H, Geisbert TW,. Ebola haemorrhagic fever. Lancet 2011; 377: 849-862.
12. Baize S, Pannetier D, Oestereich L, et al. Brief Report: Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371: 1418-1425.
13. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014; 345: 1369-1372.
14. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438: 575-576.
15. Centers for Disease Control and Prevention. Interim guidance for specimen collection, transport, testing, and submission for persons under investigation for Ebola virus disease in the United States. 2014 [cited 2014 Sep 2]. Available from: http://www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html
16. Dowell SF, Mukunu R, Ksiazek TG, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999; 179 (Suppl 1): S87-91.
17. Alimonti J, Leung A, Jones S, et al. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep 2014; 4: 1-7.
18. Centers for Disease Control and Prevention. Information for healthcare workers. 2014 [cited 2014 Sep 1]. Available from: http://www.cdc.gov/vhf/ebola/hcp/index.html
19. Ribner E,. Ebola: lessons learned, from ID Week 2014. 2014 [cited 2014 Oct 16]. Available from: http://www.idweek.org/ebola-idweek-2014/
20. Richards GA, Murphy S, Jobson R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 2000; 28: 240-244.
21. Amorosa V, MacNeil A, McConnell R, et al. Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis 2010; 16: 1598-1600.
22. Centers for Disease Control and Prevention (CDC). Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR Morb Mortal Wkly Rep 2009; 58: 1377-1381.
23. Timen A, Koopmans MP, Vossen AC, et al. Response to imported case of Marburg hemorrhagic fever, in the Netherlands. Emerg Infect Dis 2009; 15: 1171-1175.
24. Centers for Disease Control and Prevention (CDC). Imported Lassa fever-New Jersey, 2004. MMWR Morb Mortal Wkly Rep 2004; 53: 894-897.
25. Centers for Disease Control and Prevention. Malaria surveillance-United States, 2011. MMWR Surveill Summ 2013; 62 (No. SS-5): 1-17.
26. Fischer WA, Hynes NA, Perl TM,. Ideas and Opinions. Protecting health care workers from Ebola: personal protective equipment is critical but is not enough. Ann Intern Med 2014 August 26. doi: 10.7326/M14-1953.
27. Klompas M, Diekema DJ, Fishman NO, et al. Ideas and Opinions. Ebola fever: reconciling Ebola planning with Ebola risk in US hospitals. Ann Intern Med 2014 August 21. doi: 10.7326/M14-1918.
28. Malm H, May T, Francis LP, et al. Ethics, pandemics and the duty to treat. Am J Bioeth 2008; 8: 5-19.